The Journal of Organic Chemistry
Article
7.69−7.54 (m, 6H, ArH), 7.54−7.44 (m, 6H, ArH), 7.33 (d, J = 8.2
Hz, 2H, ArH); 13C NMR (100 MHz, CDCl3) (δ, ppm) 132.6, 132.1,
129.6, 129.1, 128.8, 128.7, 128.6, 128.4, 127.2, 126.5,64.3; HRMS
(APCI) m/z calcd for C30H19Br2I2N6 876.8103 [M + H]+, found
876.8123.
(APCI) m/z calcd for C20H16Cl2N6 411.0886 [M + H]+, found
411.0848.
(E)-1,2-Bis(1-methyl-1H-pyrazol-5-yl)diazene (3h): yellow solid
(eluent, petroleum ether/ethyl acetate 30:1 v/v), 0.035 g; yield 37%;
mp 77−78 °C; IR (KBr, ν, cm−1)1730, 1571, 1447, 1335, 1287, 1124,
1075, 968, 873, 833, 744; 1H NMR (400 MHz, CDCl3) (δ, ppm) 7.71
(dd, J = 9.0, 4.0 Hz, 1H, CH), 7.61 (s, 2H, CH), 7.53 (dd, J = 5.4, 3.0
Hz, 1H, CH), 4.27 (s, 6H, CH3); 13C NMR (100 MHz, CDCl3) (δ,
ppm) 144.9, 130.9, 128.8, 42.2; HRMS (APCI) m/z calcd for C8H11N6
191.1045 [M + H]+, found 191.1040.
Example for the Synthesis of 3a. (E)-1,2-Bis(3-methyl-1-phenyl-
1H-pyrazol-5-yl)diazene. 3-Methyl-1-phenyl-1H-pyrazol-5-amine (1a,
1 mmol, 173 mg) was introduced in a 25 mL reaction flask. CuI (0.05
mmol, 9.5 mg), 1,10-phenanthroline (0.15 mmol, 27 mg), and CH2Cl2
(2.0 mL) as well as aq TBHP (TBHP 70% solution in water, 0.15 mL,
1.5 mmol) were then successively added and the mixture stirred at
room temperature for 2 h. After the completion of the reaction
(monitored by TLC), the solvent was removed under vacuum. The
residue was separated by column chromatography on silica gel (eluent,
petroleum ether/ethyl acetate 10:1 v/v) to afford the pure product 3a:
oil, (eluent, petroleum ether/ethyl acetate 10:1 v/v), 0.096 g; yield
56%; IR (KBr, ν, cm−1)1597, 1517, 1422, 1343, 1141, 1021, 831, 764,
(E)-1,2-Bis(1-ethyl-1H-pyrazol-5-yl)diazene (3i): yellow solid (elu-
ent, petroleum ether/ethyl acetate 30:1 v/v), 0.031 g; yield 28%; mp
91−92 °C; IR (KBr, ν, cm−1)1520, 1464, 1363, 1190, 1082, 968, 855,
1
819, 722; H NMR (400 MHz, CDCl3) (δ, ppm) 7.51 (s, 2H, CH),
7.06 (s, 2H, CH), 4.66 (q, J = 7.2 Hz, 4H, CH2), 1.50 (t, J = 7.2 Hz,
6H, CH3); 13C NMR (100 MHz, CDCl3) (δ, ppm) 137.8, 128.8,
106.7, 48.6, 15.2; HRMS (APCI) m/z calcd for C10H15N6 219.1358
[M + H]+, found 219.1388.
1
693; H NMR (400 MHz, CDCl3) (δ, ppm) 7.49 (d, J = 5.6 Hz, 6H,
ArH), 7.41−7.35 (m, 4H, ArH), 6.99 (s, 2H, CH), 2.38 (s, 6H, CH3);
13C NMR (100 MHz, CDCl3) (δ, ppm) 148.9, 138.7, 129.34, 129.1,
128.8, 125.7, 125.0, 124.8, 106.6, 13.8; HRMS (APCI) m/z calcd for
C20H19N6 343.1666 [M + H]+, found 343.1701.
(E)-1,2-Bis(1-(4-bromophenyl)-3-phenyl-1H-pyrazol-5-yl)diazene
(3j): yellow solid (eluent, petroleum ether/ethyl acetate 30:1 v/v),
0.131 g; yield 42%; mp 161−163 °C; IR (KBr, ν, cm−1)1588, 1526,
1
1505, 1422, 1345, 1069, 1006, 834, 765, 685; H NMR (400 MHz,
(E)-1,2-Bis(1,3-dimethyl-1H-pyrazol-5-yl)diazene (3b): yellow
solid (eluent, petroleum ether/ethyl acetate 10:1 v/v), 0.056 g; yield
51%; mp 140−144 °C; IR (KBr, ν, cm−1) 1598, 1521, 1444, 1341,
CDCl3) (δ, ppm) 7.84 (d, J = 7.7 Hz, 4H, ArH), 7.67 (d, J = 8.6 Hz,
4H, ArH), 7.53−7.37 (m, 10H, ArH), 7.35 (s, 2H, CH); 13C NMR
(100 MHz, CDCl3) (δ, ppm) 151.5, 137.8, 132.4, 130.7, 129.4, 129.0,
127.5, 125.8, 123.7, 119.6, 104.2; HRMS (APCI) m/z calcd for
C30H21Br2N6 625.0170 [M + H]+, found 625.0174.
1
1028, 993, 837, 742; H NMR (400 MHz, CDCl3) (δ, ppm) 6.33 (s,
2H, CH), 4.11 (s, 6H, CH3), 2.32 (s, 6H, CH3); 13C NMR (100 MHz,
CDCl3) (δ, ppm) 130.9, 128.9, 93.1, 35.6, 19.2, 13.9; HRMS (APCI)
m/z calcd for C10H15N6 219.1358 [M + H]+, found 219.1358.
(E)-1,2-bis(3-cyclopropyl-1-methyl-1H-pyrazol-5-yl)diazene (3c):
red oil (eluent, petroleum ether/ethyl acetate 10:1 v/v), 0.093 g;
yield 69%; IR (KBr, ν, cm−1)2926, 1653, 1517, 1448, 1289, 1008, 785,
679; 1H NMR (400 MHz, CDCl3) (δ, ppm) 6.72 (s, 2H, CH), 4.16 (s,
6H, CH3), 1.99−1.82 (m, 2H, CH), 1.00−0.93 (m, 4H, CH2), 0.81−
0.70 (m, 4H, CH2); 13C NMR (100 MHz, CDCl3) (δ, ppm) 163.9,
153.5, 102.6, 40.5, 9.0, 8.1; HRMS (APCI) m/z calcd for C14H19N6
271.1671 [M + H]+, found 271.1673.
(E)-1,2-Bis(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)diazene (3d):
brown oil (eluent, petroleum ether/ethyl acetate 20:1 v/v), 0.121 g;
yield 57%; IR (KBr, ν, cm−1) 2955, 1596, 1522, 1419, 1345, 1234, 985,
815, 774, 697; 1H NMR (400 MHz, CDCl3) (δ, ppm) 7.51−7.45 (m,
6H, ArH), 7.42−7.38 (m, 4H, ArH), 7.06 (s, 2H, CH), 1.37 (s, 18H,
CH3); 13C NMR (100 MHz, CDCl3) (δ, ppm) 161.8, 138.9, 129.2,
129.1, 128.8, 125.8, 103.8, 32.6, 30.3; HRMS (APCI) m/z calcd for
C26H31N6 427.2610 [M + H]+, found 427.2623.
Example for the Synthesis of 5a. (E)-1,2-Bis(3-methyl-1-phenyl-4-
(phenylethynyl)-1H-pyrazol-5-yl)diazene. Under an argon atmos-
phere, (E)-1,2-bis(4-iodo-3-methyl-1-phenyl-1H-pyrazol-5-yl)diazene
(2a) (593 mg, 1 mmol) and CuI (19 mg, 0.1 mmol) as well as
bis(triphenylphosphine)palladium(II) chloride (35 mg, 0.05 mmol)
were introduced into a 25 mL Schlenk reaction flask, and
ethynylbenzene 3a (208 mg, 2 mmol) and TEA (4 mL) were then
successively added into this reaction mixture. The reaction system was
stirred at 50 °C for 12 h. After completion of the reaction (monitored
by TLC), the TEA was removed under vacuum. The residue was
purified by flash column chromatography (silica gel, mixtures of
petroleum ether/ethyl acetate, 40:1, v/v) to afford the pure product
5a: red solid, 0.190 g; yield 35%; mp 192−193 °C; IR (KBr, ν, cm−1)
1
2287, 1594, 1500, 1464, 1366, 1117, 807, 750, 686. H NMR (400
MHz, CDCl3) (δ, ppm) 7.82 (d, J = 8.0 Hz, 4H, ArH), 7.29−7.28 (m,
2H, ArH), 7.24−7.19 (m, 8H, ArH), 7.12−7.08 (m, 6H, ArH), 2.49 (s,
6H, CH3); 13C NMR (100 MHz, CDCl3) (δ, ppm) 153.1, 152.5,
138.7, 131.5, 128.8, 128.2, 128.1, 127.5, 124.4, 123.2, 95.3, 93.9, 81.9,
12.8; HRMS (ESI) m/z calcd for C36H27N6 543.2297 [M + H]+, found
543.2306.
(E)-1,2-Bis(3-methyl-1-p-tolyl-1H-pyrazol-5-yl)diazene (3e): yel-
low solid (eluent, petroleum ether/ethyl acetate 20:1 v/v), 0.143 g;
yield 77%; mp 82−83 °C; IR (KBr, ν, cm−1) 2924, 1698, 1509, 1434,
(E)-1,2-Bis(3-methyl-1-phenyl-4-(p-tolylethynyl)-1H-pyrazol-5-yl)-
diazene (5b): red solid, 0.291 g, yield 51%; mp 204−205 °C; IR (KBr,
ν, cm−1) 2203, 1594, 1505, 1420, 1364, 1116, 815, 755, 690. 1H NMR
(400 MHz, CDCl3) (δ, ppm) 7.84 (d, J = 8.0 Hz, 4H, ArH), 7.24−
7.20 (m, 4H, ArH), 7.15−7.12 (m, 2H, ArH), 7.04−6.98 (m, 8H,
ArH), 2.49 (s, 6H, CH3), 2.36 (d, J = 6.4 Hz, 6H, CH3); 13C NMR
(100 MHz, CDCl3) (δ, ppm) 153.0, 152.5, 138.7, 138.3, 131.4, 128.9,
128.8, 127.5, 124.4, 120. 1, 95.5, 94.1, 81.3, 21.6, 12.8; HRMS (ESI)
m/z calcd for C38H31N6 571.2610 [M + H]+, found 571.2638.
(E)-1,2-Bis(4-((4-tert-butylphenyl)ethynyl)-3-methyl-1-phenyl-1H-
pyrazol-5-yl)diazene (5c): red solid, 0.327 g; yield 50%; mp 208−209
°C; IR (KBr, ν, cm−1) 2210, 1594, 1499, 1461, 1363, 1101, 833, 756,
1
1349, 1020, 840, 814, 740; H NMR (400 MHz, CDCl3) (δ, ppm)
7.28 (d, J = 8.6 Hz, 6H, ArH), 7.25 (d, J = 8.8 Hz, 2H, ArH), 6.97 (s,
2H, CH), 2.43 (s, 6H, CH3), 2.37 (s, 6H, CH3); 13C NMR (100 MHz,
DMSO-d6) (δ, ppm) 143.5, 134.3, 131.0, 124.4, 120.2, 101.1, 25.7,
16.0, 8.6; HRMS (APCI) m/z calcd for C22H25N6 373.2141 [M + H]+,
found 373.2153.
(E)-1,2-Bis(1-phenyl-3-p-tolyl-1H-pyrazol-5-yl)diazene (3f): yellow
solid (eluent, petroleum ether/ethyl acetate 15:1 v/v), 0.124 g; yield
50%; mp 157−158 °C; IR (KBr, ν, cm−1) 1595, 1506, 1423, 1332,
1012, 950, 806, 765, 689; 1H NMR (400 MHz, CDCl3) (δ, ppm) 7.75
(d, J = 8.0 Hz, 4H, ArH), 7.59−7.50 (m, 7H, ArH), 7.49−7.40 (m, 7H,
ArH), 7.27 (s, 2H, CH), 2.40 (s, 6H, CH3); 13C NMR (100 MHz,
CDCl3) (δ, ppm) 151.2, 139.3, 138.9, 129.8, 129.6, 129.5, 129.2, 128.2,
125.9, 125.7, 103.7, 21.4; HRMS (APCI) m/z calcd for C32H27N6
495.2297 [M + H]+, found 495.2287.
1
688. H NMR (400 MHz, CDCl3) (δ, ppm) 7.81 (d, J = 8.2 Hz, 4H,
ArH), 7.24−7.22 (m, 4H, ArH), 7.19−7.16 (m, 4H, ArH), 7.08−7.04
(m, 6H, ArH), 2.48 (s, 6H, CH3), 1.32 (s, 18H, CH3); 13C NMR (100
MHz, CDCl3) (δ, ppm) 152.9, 152.5, 151.5, 138.7, 131.2, 128.7, 127.3,
125.1, 124.4, 120.2, 95.6, 94.1, 81.3, 34.8, 31.2, 12.8; HRMS (ESI) m/z
calcd for C44H43N6 655.3549 [M + H]+, found 655.3550.
(E)-1,2-Bis(3-methyl-1-phenyl-4-(m-tolylethynyl)-1H-pyrazol-5-
yl)diazene (5d): red solid, 0.182 g, yield 32%; mp 161−163 °C; IR
(KBr, ν, cm−1) 2273, 1596, 1499, 1409, 1366, 1158, 784, 752, 687. 1H
NMR (400 MHz, CDCl3) (δ, ppm) 7.84 (d, J = 8.2 Hz, 4H, ArH),
7.20−7.18 (m, 4H, ArH), 7.14−7.06 (m, 6H, ArH), 6.97−6.90 (m,
(E)-1,2-Bis(3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-yl)diazene
(3g): yellow solid (eluent, petroleum ether/ethyl acetate 15:1 v/v),
0.131 g; yield 64%; mp 132−133 °C; IR (KBr, ν, cm−1) 1600, 1543,
1
1494, 1437, 1333, 1091, 951, 837, 819, 743; H NMR (400 MHz,
CDCl3) (δ, ppm) 7.72 (d, J = 8.4 Hz, 4H, ArH), 7.41 (d, J = 8.4 Hz,
4H, ArH), 7.30 (s, 2H, CH), 4.30 (s, 6H, CH3); 13C NMR (100 MHz,
CDCl3) (δ, ppm) 148.4, 134.9, 129.8, 129.1, 126.8, 102.7, 41.0; HRMS
4023
dx.doi.org/10.1021/jo5004967 | J. Org. Chem. 2014, 79, 4018−4024